SPFI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SPFI is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a clear entry. The stock is near short-term support, but the technical trend is still weak, options sentiment is mildly bullish, and there is no fresh catalyst from news or insider/congress activity. Analyst sentiment is positive overall, but the recent target cut and loan growth concern make the setup better for waiting than buying aggressively today.
Current price is 39.16, essentially sitting between pivot 40.062 and support S1 38.912. MACD histogram is -0.308 and still below zero, which keeps the short-term trend bearish. RSI_6 at 24.914 suggests the stock is very weak but not showing a clean reversal signal yet. Moving averages are converging, which often points to a possible inflection, but not confirmation. Overall, the technical picture is neutral-to-bearish with price close to support rather than in a confirmed uptrend.
["Piper Sandler keeps an Overweight rating and still has a $46 price target.", "Last reported quarter showed core EPS beat consensus and was in-line with Piper's estimates.", "Deposit growth was strong at 15.8% end-of-period, which supports the balance sheet.", "Analyst sentiment improved recently with an upgrade from Neutral to Overweight.", "No recent news-driven negatives were reported in the last week."]
["Piper lowered the price target from $48 to $46, showing slightly reduced upside expectations.", "Loans declined 5.2%, which is a headwind for forward earnings.", "MACD remains negative and momentum is still weak.", "No AI Stock Picker signal today.", "No SwingMax entry signal recently.", "No recent insider buying, hedge fund accumulation, or congress trading activity."]
Latest quarter season is Q1 2026 based on the April 30, 2026 analyst update. The reported quarter was solid overall: core EPS of 91 cents beat consensus and matched Piper's expectations. The main concern was a 5.2% decline in loans, but this was partly offset by impressive 15.8% end-of-period deposit growth, which should help balance sheet support in Q2. Since the direct financial snapshot data was unavailable, the most reliable read is that earnings quality looked decent, deposit growth was strong, and loan growth remains the key area to watch.
Analyst trend is constructive but slightly tempered. Piper Sandler upgraded SPFI from Neutral to Overweight on 2026-03-02 and raised the target to $48 from $45, then later on 2026-04-30 kept Overweight but lowered the target to $46 from $48. That means Wall Street pros still view the stock positively, but are becoming a bit more cautious on near-term upside because of weaker loan growth. Overall, the pros see more upside than downside, but not enough to call this an aggressive buy at today's price.
